loadpatents
Patent applications and USPTO patent grants for Carr; Francis J..The latest application filed is for "polypeptides comprising a modified bacteriophage g3p amino acid sequence lacking a glycosylation signal".
Patent | Date |
---|---|
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor Grant 11,261,251 - Freeman , et al. March 1, 2 | 2022-03-01 |
Polypeptides Comprising A Modified Bacteriophage G3p Amino Acid Sequence Lacking A Glycosylation Signal App 20210015895 - Krishnan; Rajaraman ;   et al. | 2021-01-21 |
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal Grant 10,722,551 - Krishnan , et al. | 2020-07-28 |
Human Anti-pd-1, Pd-l1, And Pd-l2 Antibodies And Uses Therefor App 20200172616 - FREEMAN; Gordon J. ;   et al. | 2020-06-04 |
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor Grant 10,370,448 - Freeman , et al. | 2019-08-06 |
Humanized Anti-tau Antibodies App 20180371066 - WEST; Tim ;   et al. | 2018-12-27 |
Human Anti-pd-1, Pd-l1, And Pd-l2 Antibodies And Uses Therefor App 20180371084 - FREEMAN; Gordon J. ;   et al. | 2018-12-27 |
Polypeptides Comprising A Modified Bacteriophage G3p Amino Acid Sequence Lacking A Glycosylation Signal App 20180207231 - Krishnan; Rajaraman ;   et al. | 2018-07-26 |
Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor Grant 10,011,656 - Freeman , et al. July 3, 2 | 2018-07-03 |
Humanized anti-tau antibodies Grant 9,957,317 - West , et al. May 1, 2 | 2018-05-01 |
Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1 (IGF-1) App 20180016340 - CLEMMONS; David ;   et al. | 2018-01-18 |
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1) Grant 9,587,024 - Clemmons , et al. March 7, 2 | 2017-03-07 |
Humanized Anti-tau Antibodies App 20170058024 - West; Tim ;   et al. | 2017-03-02 |
Human Anti-pd-1, Pd-l1, And Pd-l2 Antibodies And Uses Therefor App 20160137731 - FREEMAN; Gordon J. ;   et al. | 2016-05-19 |
Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor I (IGF-1) App 20150259422 - CLEMMONS; David ;   et al. | 2015-09-17 |
Human anti-PD-1 antibodies and uses therefor Grant 9,102,727 - Freeman , et al. August 11, 2 | 2015-08-11 |
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1) Grant 9,073,996 - Clemmons , et al. July 7, 2 | 2015-07-07 |
Cytotoxins comprising modified bouganin toxin for the treatment of cancer App 20150018526 - BAKER; Matthew ;   et al. | 2015-01-15 |
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) Grant 8,758,757 - Cardarelli , et al. June 24, 2 | 2014-06-24 |
Cytotoxins comprising modified bouganin toxin for the treatment of cancer Grant 8,716,234 - Baker , et al. May 6, 2 | 2014-05-06 |
Monoclonal Antibodies For Enhancing Or Inhibiting Insulin-like Growth Factor 1 (igf-1) App 20140072568 - Clemmons; David ;   et al. | 2014-03-13 |
Human Anti-pd-1, Pd-l1, And Pd-l2 Antibodies And Uses Therefor App 20130291136 - FREEMAN; Gordon J. ;   et al. | 2013-10-31 |
Anti-PD-L1 antibodies and uses therefor Grant 8,552,154 - Freeman , et al. October 8, 2 | 2013-10-08 |
Multispecific Deimmunized Cd3-binders App 20130224205 - HOFMEISTER; Robert ;   et al. | 2013-08-29 |
Multispecfic deimmunized CD3-binders Grant 8,076,459 - Hofmeister , et al. December 13, 2 | 2011-12-13 |
Human Anti-pd-1, Pd-l1, And Pd-l2 Antibodies And Uses Therefor App 20110271358 - Freeman; Gordon J. ;   et al. | 2011-11-03 |
Methods for reducing immunogenicity of polypeptides Grant 7,939,295 - Carr , et al. May 10, 2 | 2011-05-10 |
Humanized Antibodies To Interferon Alpha Receptor-1 (ifnar-1) App 20110086422 - Cardarelli; Josephine M. ;   et al. | 2011-04-14 |
Modified anti-CD52 antibody Grant 7,910,104 - Carr , et al. March 22, 2 | 2011-03-22 |
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) Grant 7,888,484 - Cardarelli , et al. February 15, 2 | 2011-02-15 |
Carrier molecules App 20100286375 - Carr; Francis J. ;   et al. | 2010-11-11 |
Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof App 20100254964 - Baker; Matthew ;   et al. | 2010-10-07 |
TNF alpha-binding polypeptide compositions and methods Grant 7,754,853 - Hellendoorn , et al. July 13, 2 | 2010-07-13 |
Modified bouganin proteins, cytotoxins and methods and uses thereof Grant 7,750,136 - Baker , et al. July 6, 2 | 2010-07-06 |
Humanized Antibodies To Interferon Alpha Receptor-1 (ifnar-1) App 20100104569 - Cardarelli; Josephine M. ;   et al. | 2010-04-29 |
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) Grant 7,619,070 - Cardarelli , et al. November 17, 2 | 2009-11-17 |
Artificial proteins with reduced immunogenicity Grant 7,615,217 - Gillies , et al. November 10, 2 | 2009-11-10 |
Modified interferon beta with reduced immunogenicity Grant 7,615,615 - Carr , et al. November 10, 2 | 2009-11-10 |
Protein isolation and analysis App 20090233806 - Carr; Francis J. | 2009-09-17 |
T Cell Assays App 20090221024 - Baker; Matthew ;   et al. | 2009-09-03 |
Modified anti-TNF alpha antibody Grant 7,524,502 - Hellendoorn , et al. April 28, 2 | 2009-04-28 |
Carrier molecules App 20090092546 - Carr; Francis J. ;   et al. | 2009-04-09 |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies Grant 7,514,078 - Bander , et al. April 7, 2 | 2009-04-07 |
Modified interferon beta with reduced immunogenicity App 20090043076 - Carr; Francis J. ;   et al. | 2009-02-12 |
Multispecific deimmunized CD3-binders App 20090022738 - Hofmeister; Robert ;   et al. | 2009-01-22 |
Carrier molecules Grant 7,459,143 - Carr , et al. December 2, 2 | 2008-12-02 |
Modified Anti-cd52 Antibody App 20080248529 - CARR; FRANCIS J. ;   et al. | 2008-10-09 |
Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity Grant 7,430,476 - Carr , et al. September 30, 2 | 2008-09-30 |
Modified Bouganin Proteins, Cytotoxins And Methods And Uses Thereof App 20080219994 - Baker; Matthew ;   et al. | 2008-09-11 |
Method of preparing a modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicity Grant 7,392,141 - Carr , et al. June 24, 2 | 2008-06-24 |
Modified interferon beta with reduced immunogenicity Grant 7,381,795 - Carr , et al. June 3, 2 | 2008-06-03 |
Protein isolation and analysis Grant 7,351,540 - Carr April 1, 2 | 2008-04-01 |
Modified Anti-cd52 Antibody App 20080075715 - CARR; FRANCIS J. ;   et al. | 2008-03-27 |
Modified bouganin proteins, cytotoxins and methods and uses thereof Grant 7,339,031 - Baker , et al. March 4, 2 | 2008-03-04 |
De-Immunized Anti-Cd3 Antibody App 20070292416 - Rother; Russell P. ;   et al. | 2007-12-20 |
Artificial proteins with reduced immunogenicity App 20070269435 - Gillies; Stephen ;   et al. | 2007-11-22 |
Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon App 20070224196 - Himawan; Jeff ;   et al. | 2007-09-27 |
Modified anti-CD52 antibody Grant 7,264,806 - Carr , et al. September 4, 2 | 2007-09-04 |
Anti-KSA/IL-2 fusion proteins with reduced immunogenicity Grant 7,189,830 - Gillies , et al. March 13, 2 | 2007-03-13 |
Modified anti-EGFR antibodies with reduced immunogenicity Grant 7,132,511 - Carr , et al. November 7, 2 | 2006-11-07 |
Carrier molecules App 20060239912 - Carr; Francis J. ;   et al. | 2006-10-26 |
Carrier molecules Grant 7,087,724 - Carr , et al. August 8, 2 | 2006-08-08 |
Modified antibodies to prostate-specific membrane antigen and uses thereof Grant 7,045,605 - Bander , et al. May 16, 2 | 2006-05-16 |
Modified interferon alpha with reduced immunogenicity App 20060062761 - Carr; Francis J. ;   et al. | 2006-03-23 |
T-cell epitopes in erythropoietin App 20060035322 - Baker; Matthew ;   et al. | 2006-02-16 |
Modified bryodin 1 with reduced immunogenicity App 20060019885 - Baker; Matthew ;   et al. | 2006-01-26 |
TNF alpha-binding polypeptide compositions and methods App 20060018903 - Hellendoorn; Koen ;   et al. | 2006-01-26 |
Pharmaceuticals and assays using enzyme subunits Grant 6,974,699 - Titball , et al. December 13, 2 | 2005-12-13 |
Modified factor VIII App 20050256304 - Jones, Tim ;   et al. | 2005-11-17 |
Modified bouganin proteins, cytotoxins and methods and uses thereof App 20050238642 - Baker, Matthew ;   et al. | 2005-10-27 |
T-cell epitopes in staphylococcal enterotoxin b App 20050240009 - Carr, Francis J. ;   et al. | 2005-10-27 |
Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine App 20050222392 - Carter, Graham ;   et al. | 2005-10-06 |
Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) App 20050208041 - Cardarelli, Josephine M. ;   et al. | 2005-09-22 |
Method for mapping and eliminating T cell epitopes App 20050181459 - Baker, Matthew ;   et al. | 2005-08-18 |
Deimmunized binding molecules to CD3 App 20050176028 - Hofmeister, Robert ;   et al. | 2005-08-11 |
Modified anti-CD52 antibody App 20050152898 - Carr, Francis J. ;   et al. | 2005-07-14 |
T-cell epitodes in carboxypeptidase g2 App 20050074863 - Hellendoorn, Koen ;   et al. | 2005-04-07 |
Modified interferon beta with reduced immunogenicity App 20050054052 - Carr, Francis J. ;   et al. | 2005-03-10 |
Modified human growth hormone App 20050020494 - Carr, Francis J ;   et al. | 2005-01-27 |
Modified anti-tnf aplha antibody App 20040260069 - Hellendoorn, Koen ;   et al. | 2004-12-23 |
Modified factor ix App 20040254106 - Carr, Francis J. ;   et al. | 2004-12-16 |
Modified antibodies to prostate-specific membrane antigen and uses thereof App 20040213791 - Bander, Neil ;   et al. | 2004-10-28 |
Methods for reducing immunogenicity of polypeptides App 20040185038 - Carr, Francis J ;   et al. | 2004-09-23 |
Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity App 20040180386 - Carr, Francis J. ;   et al. | 2004-09-16 |
Modified antibodies to prostate-specific membrane antigen and uses thereof App 20040120958 - Bander, Neil H. ;   et al. | 2004-06-24 |
Modified protamine with reduced immunogenicity App 20040121443 - Carr, Francis J. ;   et al. | 2004-06-24 |
Modified anti-egfr antibodies with reduced immunogenicity App 20040096442 - Carr, Francis J. ;   et al. | 2004-05-20 |
Modified ciliary neurotrophic factor (cntf ) with reduced immunogenicity App 20040087503 - Carr, Francis J. ;   et al. | 2004-05-06 |
Artificial proteins with reduced immunogenicity App 20040082039 - Gillies, Stephen ;   et al. | 2004-04-29 |
Modified interleukin-1 receptor antagonist(il-1ra) with reduced immunogenicity App 20040076991 - Carr, Francis J. ;   et al. | 2004-04-22 |
Modified thrombopoietin with reduced immunogenicity App 20040071688 - Carr, Francis J. ;   et al. | 2004-04-15 |
Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity App 20040072291 - Carr, Francis J. ;   et al. | 2004-04-15 |
Modified leptin with reduced immunogenicity App 20040072219 - Carr, Francis J. ;   et al. | 2004-04-15 |
Modified erythropoietin (epo) with reduced immunogenicity App 20040063917 - Carr, Francis J. ;   et al. | 2004-04-01 |
Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity App 20040062749 - Carr, Francis J. ;   et al. | 2004-04-01 |
Modified kertinocyte growth factor (kgf) with reduced immunogenicity App 20040063634 - Carr, Francis J. ;   et al. | 2004-04-01 |
Peptides presented by cells App 20030171290 - Carr, Francis J. ;   et al. | 2003-09-11 |
Carrier molecules App 20030124056 - Carr, Francis J. ;   et al. | 2003-07-03 |
Pharmaceuticals and assays using enzyme subunits App 20020035084 - Titball, Richard W. ;   et al. | 2002-03-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.